Rituximab Biosimilar - Research Grade

• Specifications:

  Detects human CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Rituximab.

• Product Name Alternative:

  B-lymphocyte surface antigen B1, Bp35, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1, MS4A1

• Host:

  Humanized

• Species Reactivity:

  Human

• Target:

  CD20

• Purification Method:

  This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

• Concentration:

  1.0 - 5.0 mg/mL

• Endotoxin:

  ≤ 1.0 EU/mg as determined by the LAL method

• Purity:

  >95% by SDS-PAGE and HPLC

• Buffer:

  ICH3001-100mL ICH3002-100mL ICH3003-100mL

• Storage Conditions:

  Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.

• Formulation:

  Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

• Isotype Control:

  https://ichor.bio/product/bulk-human-igg1-isotype-control-ib1-ich2254/